Bempedoic Acid; Ezetimibe Patent Expiration
Bempedoic Acid; Ezetimibe is Used for lowering LDL cholesterol and treating heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease. It was first introduced by Esperion Therapeutics Inc
Bempedoic Acid; Ezetimibe Patents
Given below is the list of patents protecting Bempedoic Acid; Ezetimibe, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nexlizet | US11613511 | Methods of making bempedoic acid and compositions of the same | Jun 19, 2040 | Esperion Theraps Inc |
| Nexlizet | US11760714 | Methods of making bempedoic acid and compositions of the same | Jun 19, 2040 | Esperion Theraps Inc |
| Nexlizet | US11926584 | Methods of making bempedoic acid and compositions of the same | Jun 19, 2040 | Esperion Theraps Inc |
| Nexlizet | US10912751 | Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | Mar 14, 2036 | Esperion Theraps Inc |
| Nexlizet | US11744816 | Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | Mar 14, 2036 | Esperion Theraps Inc |
| Nexlizet | US7335799 | Hydroxyl compounds and compositions for cholesterol management and related uses | Dec 03, 2030 | Esperion Theraps Inc |
| Nexlizet | US10118881 | Hydroxyl compounds and compositions for cholesterol management and related uses |
Dec 23, 2023
(Expired) | Esperion Theraps Inc |
| Nexlizet | US10941095 | Hydroxyl compounds and compositions for cholesterol management and related uses |
Dec 23, 2023
(Expired) | Esperion Theraps Inc |
| Nexlizet | US8497301 | Hydroxyl compounds and compositions for cholesterol management and related uses |
Dec 23, 2023
(Expired) | Esperion Theraps Inc |
| Nexlizet | US9000041 | Hydroxyl compounds and compositions for cholesterol management and related uses |
Dec 23, 2023
(Expired) | Esperion Theraps Inc |
| Nexlizet | US9624152 | Hydroxyl compounds and compositions for cholesterol management and related uses |
Dec 23, 2023
(Expired) | Esperion Theraps Inc |
Bempedoic Acid; Ezetimibe's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List